Erelzi (etanercept)

pCPA File Number: 20981

Negotiation Status:

Concluded with an LOI

Indication(s):

Ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis

Sponsor/Manufacturer:

Sandoz Canada Inc.

CDA-AMC Project Number:

SE0513-000

pCPA Engagement Letter Issued:

2017-04-21

Negotiation Process Concluded:

2017-10-17